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ABSTRACT
CONFIRMATION OF EMX2 PROTEIN BINDING PARTNERS
by
Cody David Gillman
November 2016

The neocortex is a structure within mammalian brains that processes sensory
input from eyes, ears, and touch receptors and mediates the conscious use of skeletal
muscles. The processing of information related to each of these types of functions is
localized within discrete areas of the neocortex, which are separated by sharp borders.
Proper development of these functional areas is regulated during embryogenesis by
several transcription factors that are expressed in distinct gradients across the
progenitor layer of the neocortex, the ventricular zone. Despite the vast amount of
progress that has been made in describing how these transcription factors impact the
organization of the neocortex, much more work is still needed to elucidate the molecular
mechanisms that involve these proteins. An important step in this process is identifying
proteins that bind these various transcription factors. The goal of this project was to
confirm protein binding partners for the neocortical transcription factor Emx2, which
were previously identified in the Kroll lab. Pull-down assays were performed to test the
protein-protein interactions between Emx2 and QkI-7, Emx2 and Cnot6l, and Cnot6l and
QkI-7. The results were positive for all three interactions. Additionally, Emx2 was found
to bind the two other QkI isoforms, QkI-5 and QkI-6.
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CHAPTER I
INTRODUCTION
Introduction to the neocortex
The neocortex is a brain structure located at the outermost part of the
mammalian cerebral cortex composed of six layers of unmyelinated neurons (grey
matter) that associate with deeper myelinated neurons (white matter), which extend
through the internal capsule to the dorsal thalamus. The neocortex is one of two
cerebral structures; the other is the allocortex, which is smaller and consists of only
three neural layers that comprise the hippocampus and olfactory regions (Pellegrini et
al., 1996). The primary responsibilities of the neocortex include processing sensory
input from visual, somatosensory, and auditory receptors, and mediating voluntary
(conscious) use of skeletal muscles (O’Leary and Sahara, 2008). These four basic
functions are managed by discrete neuronal structures within the neocortex that are
referred to as the primary cortical areas. In higher mammals, there are also secondary
and associative areas that are important for specialized behaviors (Lui et al., 2011).
Secondary and associative areas are typically considered to be
extensions/modifications of the primary areas and the number of these areas varies
widely between individual species. It is believed that the emergence of secondary and
associative areas is the result of adaptations made in response to the ecological and/or
social niches inhabited during evolution (Kaas, 2012). An example of this phenomenon,
referred to as cortical magnification, is the development of a secondary area in humans
called Broca’s area, which coordinates muscle movement in the lips, tongue, larynx and
other oral structures necessary for communication through speech (Krubitzer, 2007).
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Another example is the dramatic enlargement of the somatosensory area in the duckbilled platypus. This modification, which is particularly important for the survival of this
nocturnal and aquatic mammal, is responsible for processing the large amounts of
information received from mechanosensory and electrosensory receptors located on the
bill (Krubitzer, 2007; Kaas, 2012).
Studies comparing the size and position of the cortical areas relative to the
cortical surface, (i.e., the cortical area map), have revealed that although the patterning
of the areas is highly variable between species, a conserved feature is the rostral-tocaudal (anterior-to-posterior) organization of the areas (Figure 1). This suggests that the
neocortex evolved from a common ancestor. Of particular interest in modern day
neocortex research is characterizing the genetic factors that specify the overall pattern
of the cortical area map during
development, which are referred to
as arealization factors. The number
of arealization factors continues to
grow and elucidating the cellular
mechanisms through which they
regulate cortex development
(corticogenesis) has been an
expanding and challenging area of
research.

Figure 1. Comparison of mouse and human
cortical maps. The mouse (left) and human
(right) neocortices are shown. In both, the
somatosensory area (red) is found rostral to
the auditory area (yellow), which is in turn
rostral to the visual area (blue). The motor
area (uncolored) is found rostral to the other
areas. M1 = motor area, S1 = somatosensory
area, A1 = auditory area, V1 = visual area.
(Krubitzer, 2007)
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Neocorticogenesis
All excitatory (glutamatergic) neocortical neurons originate from a series of
mitotic divisions of radial glia progenitor cells in the ventricular zone (VZ) of the
neocortex that begins at mouse embryonic day 11.5 (E11.5). These glial progenitors
divide in one of two manners: symmetrically or asymmetrically (Figure 2A). Symmetric
glial divisions produce “sister” cells that expand the pool of neocortical progenitors,
whereas asymmetric divisions produce excitatory “daughter” neurons that migrate
radially along glial fibers to populate the cortical plate (CP). Broader neocortices are
achieved in species such as apes and whales by generating a larger pool of progenitor
cells, which is achieved by having a greater number of symmetric divisions during early
neocorticogenesis (Kaas, 2012).
The majority of daughter neuron radial migration from the VZ to the CP takes
place from E11.5 to E18.5 to establish the six neocortical layers. The migrating
daughter neurons form layers in the CP that are laminated in an “inside-out” manner, as
successive cohorts of daughter neurons migrate past the previous cohorts (Figure 2B).
During the growth of the CP, the neurons comprising the various cortical areas are
indistinguishable by architectural differences, which are not apparent until postnatal day
7 (P7) due to cytoskeletal modifications and deterioration of non-functional axonal
connections between the areas and other adjacent structures (O’Leary and Kroll, 2009).
Despite the architectural uniformity among CP neurons before P7, area-specific
patterns of bordered gene expression are present across the CP, which suggests that
the area identity of daughter neurons is specified prenatally, during proliferation in the
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VZ. An example is the bordered expression profiles typical of the type II classical
cadherin proteins, Cadherin6 and Cadherin8 (Bishop et al., 2000).

A

B

Figure 2. Glutamatergic daughter neurons migrate radially to populate the growing
neocortex. (A) At E11, glial progenitors in the ventricular zone (VZ) begin to divide in one of
two manners: symmetrically (top) to increase the progenitor pool, or asymmetrically
(bottom) to produce glutamatergic daughter neurons. (B) The first round of daughter
neurons (purple) separates the preplate (PP) into the subplate (SP) and marginal zone
(MZ). Daughter neurons born in the VZ migrate along radial glial fibers extending from the
VZ to the MZ to populate the growing CP. The six laminated layers of the CP form in an
inside-out manner as each successive round of daughter neurons migrates superficial to the
previous round. Postnatally, the VZ/SVZ becomes non-proliferative white matter (WM) and
the MZ becomes layer 1 of the neocortex (right). (Higginbotham et al., 2011; Godin and
Nguyen, 2014)
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These are cell-adhesion proteins that are uniquely expressed in somatosensory and
auditory area neurons (Cadherin6) and motor and visual area neurons (Cadherin8). In
addition to these genes, many other marker genes that display area-specific expression
profiles have been identified.
The glutamatergic excitatory neurons that are born in the neocortical VZ are
joined by a second population of GABAergic inhibitory neurons originating from nonneocortical regions (Godin and Nguyen, 2014) These GABAergic inhibitory neurons
migrate tangentially from the caudal and medial ganglionic eminences (CGE and MGE,
respectively) and make up approximately 20% of neurons in the adult neocortex (Figure
3). Rather than following the path of a glial fiber as glutamatergic neurons do, the path
of GABAergic interneurons is determined by guidance cues received from adjacent
structures. Evidence suggests that interneuron placement in the neocortex is also

Figure 3. GABAergic interneurons are born in the medial ganglionic
eminence and migrate tangentially into the neocortex. Viewing a coronal
slice of the brain during corticogenesis, GABAergic interneurons born in the VZ
of the medial ganglionic eminence (MGE) follow a tangential path to reach the
neocortex (red lines). The caudal ganglionic eminence, along with the
GABAergic interneurons originated from it, is not visible at the reference point.
(Godin and Nguyen, 2014)
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specified at the level of the VZ progenitor layer in which they are derived (intrinsic to the
MGE and other GE structures), which adds to the complexity our understanding of the
overall scheme by which cellular programming specifies neocortical formation.
Neocortical Input and Output
The neocortical areas send projections to (corticofugal projections), and receive
input from (thalamocortical axon, or TCA, projections), the dorsal thalamus (DT), which
relays information to the neocortex from the periphery. (Figure 4) A well-characterized
example is TCA innervation originating at the ventrobasal (VB) complex of the DT,
which receives sensory communication from mouse facial whiskers, to a distinct region
within layer four of the somatosensory area called the barrel field. The neural
architecture of this region consists mainly of projection neurons that resemble rows of
barrels (Hamasaki et al., 2004). When barrel field projection neurons receive TCA input,
they project locally to associative areas that process an appropriate response to the
stimulus. The removal of TCA guidance cues intrinsic to intermediate targets of TCAs,
such as the basal ganglia primordium, results in diminished refinement of the barrels
(Lokmane et al., 2013). This observation demonstrates that TCA innervation is another
factor involved in the proper development of neocortical areas. Further investigations
will be required to determine the extent to which TCAs are involved in the regulation of
area-specific gene expression patterns.
Arealization
The arealization of the neocortex is regulated by a combination of two types of
factors: secreted morphogens and transcription factors (TFs), which regulate each other
to specify the eventual map of the neocortex. Initially, morphogens, which are secreted
6

from patterning centers adjacent to the neocortex, are the dominant force organizing
neocortical arealization, and function to control the expression of TFs
in appropriate patterns across the VZ. An example of morphogen signaling to the VZ is

Figure 4. Thalamacortical axons (TCAs) project from the dorsal thalamus (DT)
through the striatum (ST) to the neocortex (Ncx). Viewing a horizontal slice of the
mouse brain, different thalamic nuclei in the DT project to particular areas: the dorsal
lateral geniculate nucleus (dLGN) projects to the visual area (blue), the ventrobasal
complex (VB) to the somatosensory area (green), and the ventrolateral nucleus (VL)
to the motor cortex (orange). (Garel and Rubenstein, 2004)
the secretion of fibroblast growth factor 8 (Fgf8) from a patterning center called the
commissural plate. This particular morphogen predominantly regulates prefrontal cortex
development. Studies have found that when Fgf8 expression is increased in the
prefrontal cortex, the rostral neocortical areas (motor and somatosensory areas)
increase in size and the caudal areas (auditory and visual) decrease in size (CaroniaBrown et al., 2014). In addition to the influence of Fgf8, several other patterning centers
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secrete different morphogens that regulate neocortical arealization (O’Leary and
Sahara, 2008).
A growing list of TFs that are crucial to the process of arealization have been
identified and only a few have been studied to any significant degree. The four TFs with
graded expression across the VZ that have received the most attention are Emx2,
Pax6, Coup-TFI, and Sp8 (Figure 5). These TFs work in a combinatorial manner to
regulate the size and position of the cortical areas by specifying the areal identity of
daughter neurons born in the VZ (through asymmetric divisions), which has been
demonstrated in mice with mutations in these genes (O’Leary and Nakagawa, 2002).
Determining the factors that are involved in maintaining the balance between these four
key TFs and elucidating the cellular programs that they initiate to regulate arealization
has been a challenging area of research and to date receives frequent attention.

Figure 5. The major neocortical arealization TFs and their expression
gradients across the VZ. The graded expression of these TFs is regulated by
morphogens secreted from patterning centers and in a combinatorial manner they
specify cortical area size and position. Emx2 is expressed in a high caudal-medial
to low rostral-lateral concentration gradient. Pax6 is in a high rostral-lateral to low
caudal-medial gradient. Coup-TFI is in a high caudal-lateral to low rostral-medial
gradient. Sp8 is in a high rostral-medial to low caudal-lateral gradient. R = rostral,
C = caudal, L = lateral, M = medial. (O’Leary and Sahara, 2008)
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Emx2
Emx2 is a 255 amino acid (28 kDa) homeodomain TF related to the empty
spiracles (ems) gene in Drosophila melanogaster (fruit fly) (Dalton et al., 1989). Fruit fly
larva lacking ems expression are unable to develop spiracle structures in the head,
which are needed for breathing. Consistent with studies on other homeodomain
transcription factors, the highly conserved function of Emx2 is to modulate cell fate and
proliferation during embryogenesis (Bondos et al., 2004). In recent times, the role that
Emx2 has in the developing mouse neocortex (Bishop et al., 2000; Hamasaki et al.,
2004), olfactory bulb (McIntyre et al., 2008), and hippocampus (Savaskan et al., 2002)
has been extensively studied.
In the developing neocortex, Emx2 is expressed in a distinct concentration
gradient across the VZ starting at mouse E9.5 and regulates arealization until E16.5
(around the time of birth). Since most research to date has focused on Emx2’s
important role during embryonic time points, its precise role in the adult brain is still
under investigation. However, in adult mice Emx2 expression is restricted mostly to the
subependymal zone of the lateral ventricles and the dentate gyrus of the hippocampus
(Gangemi et al., 2001).
Mice that have been genetically modified either underexpress or overexpress
Emx2 in the embryonic VZ results in all areas of the cortical map to shift in the same
direction as the expression gradient, and the areas either increase or decrease in size
(Figure 6). For example, overexpression of Emx2 causes the area map to shift in the
rostral direction (Hamasaki et al., 2004). In this study, a promoter for nestin (ne), an
intermediate filament protein with expression restricted to the neocortical VZ, was
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placed upstream of an additional Emx2 allele to influence overexpression. These mice
survive into adulthood and have been studied during postnatal development (Dwyer et
al., 2011). Conversely, in Emx2 loss-of-function knockout mice, the caudal shift in
Emx2’s expression gradient causes the area map to also shift in the caudal direction
(Bishop et al., 2000). Complete loss-of-function mice do not survive past P0 due to
kidney hypoplasia and the behavioral deficiencies these mice may have cannot be
studied.

Figure 6. Changes in neocortical area size and position in Emx2 mutant mice. (A)
In wild-type (wt) mice, Emx2 is normally expressed in a high caudal-medial to low rostrallateral concentration gradient across the VZ. The normal size and shape of the areas is
shown below. (B) In ne-Emx2 mice, increased Emx2 expression causes the areas to
shift in the rostral direction, corresponding to the shift in concentration gradient (arrows).
In these mutants, along with the shift, the visual area increases in size while the others
decrease in size. (C) In Emx2 +/- (heterozygous) mice, decreased Emx2 expression
causes the areas to shift in the caudal direction, which corresponds to the shift in
concentration gradient. In this case, the motor and somatosensory areas increase in size
while the visual area decreases in size. M = motor, S1 = somatosensory, A1 = auditory,
V1 = visual. (O’Leary and Kroll, 2009)
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However, behavioral studies on overexpressing (ne-Emx2) and underexpressing
(Emx2+/-) mice demonstrate significant deficiencies in tactile and motor behaviors,
suggesting that area size and position is optimized during neurogenesis in normal mice
(Leingartner et al., 2007). Moreover, Emx2 mutants exhibit irregular TCA innervation to
the cortical areas, which likely amplifies the deficiencies observed in these mice (Bishop
et al., 2000; Dwyer et al., 2011)
Identification of Emx2 Protein Binding Partners
In the recent past, the Kroll lab identified several candidate binding partners for
Emx2 using a technique called yeast two-hybrid screening. This system utilizes a
transcription-activating protein named Gal4, which contains two domains: a DNAbinding domain and a transcription activation domain. The Gal4 DNA-binding domain
was linked to Emx2 via molecular cloning to make a bait protein and the transcription
activation domain was linked to a random library of embryonic neocortical prey proteins.
When the Emx2 bait protein interacted with a prey protein, the Gal4 protein was
reconstituted and the yeast cells were allowed to grow on media selecting for the
presence of a yeast two-hybrid interaction. Of the several potential Emx2 protein
binding partners our lab identified using yeast two-hybrid screening, this thesis project is
concerned with two: QkI-7 and Cnot6l. Intriguingly, QkI-7 and Cnot6l were also
demonstrated to interact with each other (Figure 7).
QkI-7
Quaking isoform 7 (QkI-7) is a 325 residue (36 kDa) protein. QkI-7 and its two
alternatively spliced isoforms, QkI-5 and QkI-6, are RNA-binding proteins that belong to
the highly conserved STAR (signal transduction and activation of RNA) family of
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proteins that recognize YUAAY RNA-response elements (RREs) to posttranscriptionally regulate target genes (Yang et al., 2010). Members of the STAR family
have a K-homology (KH) RNA-binding motif that is flanked on both sides by two smaller

Figure 7. Yeast two-hybrid screening reveals putative Emx2 proteinprotein interactions. Plasmids encoding bait protein (fused to the Gal4
DNA-binding domain) and the prey protein (fused to the Gal4 transcription
activation domain) were transformed into Yeast Two-Hybrid Gold strain of
Saccharomyces Cerevisiae (Clontech) and plated onto media that selects for
the presence of a two-hybrid interaction. (both panels) Control experiments
were: lane 1) expression of proteins known to interact; lane 2) expression of
proteins that do not interact. The “-“ for other lanes indicates that an empty
bait or prey plasmid was used to show that the bait does not interact with the
Gal4 transcription activation domain or the prey does not interact with the
Gal4 DNA-biding domain. (panel A) Emx2 interacts with QkI-7, when Emx2 is
either bait or prey and QkI-7 is in the complimentary plasmid. (panel B) Emx2
interacts with Cnot6l when Emx2 is the bait. The ability of Emx2 to bind
Cnot6l when Emx2 is used as the prey was not successful (data not shown).

motifs, QUA1 on the N-terminal side and QUA2 on the C-terminal side. These three
motifs together constitute the STAR domain. Members of the STAR family play major
roles during embryonic development (Vernet and Artzt, 1997). An example is the role
that the STAR protein GLD-1 has in the early development of Caenorhabditis elegans.
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GLD-1 represses translation of the Notch receptor GLP-1 by binding the 3’UTR of GLP1 mRNA. This is also crucial for maintaining the cellular localization of this transcript
(Marin, 2003). Crystal structure analysis has revealed that the QUA1 motif is necessary
for hetero- and homodimerization of the STAR proteins while the KH and QUA2 motifs
together are required for recognition of QkI RREs. There is evidence, however, that
QUA1 also enhances RNA binding strength (Chen and Richard,1998; Teplova et al.,
2013). The QkI RRE contains a core sequence of ACUAAY-N(1-20)-UAAY (Larocque
and Richard, 2005) and a recent bioinformatics analysis identified over 1,000 candidate
mRNA targets for QkI proteins in the mouse genome (Galarneau and Richard, 2005).
The QkI-5 isoform is a nuclear protein with a 30 amino acid nuclear localization
signal at its C-terminus, which is the only region that differs between the three isoforms
(Figure 8). QkI-6 and QkI-7 have 8 and 14 unique amino acid C-terminal sequences,
respectively, and are predominantly cytoplasmic. However, QkI-5 is known to shuttle
between the cytoplasm and nucleus (Wu et al., 1999) and is able to escort the other QkI
isoforms to the nucleus following heterodimerization (Pilotte et al., 2001). The QkI
proteins are generally down-regulated in cells that are fated to differentiate into neurons.
In contrast, discrete populations of progenitors in the VZ of the spinal cord that are fated
to become glial cells continue to express the QkI proteins during differentiation (Hardy,
1998). Accordingly, all QkI isoforms are expressed in both astrocyte and
oligodendrocyte glial cells and promote cell differentiation by post-transcriptionally
regulating genes that are involved in myelination, such as myelin basic protein (MBP),
the cyclin-dependent kinase (CDK) inhibitor p27KIP1, and the alternative splicing
regulator hnRNPA1 (Hardy and Friedrich, 1996; Teplova et al., 2013).
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Studies suggest that expression of the nuclear QkI-5 isoform alone suppresses
glial cell differentiation, whereas QkI-6 and QkI-7 up-regulation promote it (Larocque
and Richard, 2005). At E10.5, all cells in the spinal cord VZ express the three QkI
proteins and at P14, QKI expression is very strong in all differentiated glial cells of the
nervous system, which coincides with the substantial myelination processes that take
place during this time (Hardy, 1998). A role that the QkI isoforms may have in the
developing neocortex has not been identified and it seems more investigation in this
region is necessary.

Figure 8. The three alternatively spliced quaking isoforms. QkI-5
contains 30 unique amino acids at the C-terminus that harbor a nuclear
localization signal. QkI-6 and QkI-7 contain 8 and 14 unique residues
at the C-terminus, respectively, which require further investigation to
elucidate their intrinsic cellular function.

Homozygous quaking viable (Qkv/v) mice carry an autosomal recessive mutation
in the enhancer/promoter region of the quaking locus that prevents the expression of
QkI-6 and QkI-7, but not QkI-5, in myelinating cells (Wang et al., 2010). These mutants
are characterized by uncompacted myelin (Hogan and Greenfield, 1984) and develop
rapid tremors mostly in the hindlimbs around P10. The condition worsens as adult mice
experience tonic-clonic seizures (Sidman et al., 1964). Down-regulation of QkI-7
expression in astrocytes of the frontal cortex has been identified in schizophrenia
patients; a characteristic that QkI-7 has in common with Emx2 (Haroutunian et al., 2006;
14

Kim et al., 2007). It was also recently discovered that QkI proteins protect the transcript
of GFAP intermediate filament protein, which has also been implicated in schizophrenia,
(Radomska et al., 2013).
One study found that apoptosis (programmed cell death) was strongly induced in
NIH 3T3 fibroblast cells transfected with QkI-7 (Pilotte et al., 2001). To investigate, the
authors fused the unique 14 C-terminal amino acids of QkI-7 (EWIEMPVMPDISAH) to
heterologous proteins and cells transfected with these chimeric proteins underwent
apoptosis at the same rate. Interestingly, when QkI-7 is coexpressed with QkI-5 and
QkI-6, the cells no longer undergo apoptosis. Further, when E48G mutations were
introduced into the QUA1 domain of the QkI proteins, which hinders dimerization,
apoptosis was unsuppressed (Pilotte et al., 2001). The authors propose that
heterodimerization of QkI-5 and QkI-6 with QkI-7 neutralizes the apoptotic influence of
QkI-7 and a balance of the isoforms is necessary for survival. To date, the mechanism
by which the QkI-7 C-terminus induces apoptosis is unknown.
Cnot6l
Cnot6l is a 555 amino acid (67 kDa) protein with two domains: a carboxy-terminal
endonuclease-exonuclease-phosphatase (EEP) domain that contains an alpha/beta
sandwich fold (a motif common in hydrolases) and a leucine-rich repeat (LRR) at the
amino-terminal that contains alternating α-helices and β-sheets (Figure 9A). The EEP
domain functions as a catalytic ribonuclease and the LRR has been implicated as a
stabilizer of protein-protein and protein-DNA interactions. Deletion of the LRR abolishes
Cnot6l ribonuclease activity of the EEP (Kajava, 1998; Clark et al., 2004). Cnot6l has
one paralog, Cnot6, which contains two additional amino acids in the LRR (Figure 7B).
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In humans, Cnot6 and Cnot6l are called Ccr4a and Ccr4b, respectively. The need for
two paralogs is unclear but it is known that each is expressed in different populations of
cells (Bhandari et al., 2014). Additionally, there are several Cnot6l homologs that lack
the LRR domain, including Nocturnin, Angel, and PDE12 (Winkler and Balacco, 2013).
The LRR domain is also the binding site for the protein Caf1 (also called Cnot7),
which mediates the indirect association of Cnot6l with the Ccr4-NOTI complex (Figure
9C) (Clark et al., 2004). The large (1.2 MDa) Ccr4-NOTI complex performs multiple

Figure 9. Cnot6l and paralog, Cnot6, are members of the Ccr4-NOTI protein
complex. Cnot6 (Ccr4a in humans) and Cnot6l (Ccr4b) are paralogs that appear to
have identical functions but are expressed in different populations of cells. (panel A)
The EEP domain is found at the C-terminus and catalyzes degradation of poly(A)
mRNA tails (α-helices are blue; β-strands are yellow. The LRR domain is located at
the N-terminus of Cnot6/l and mediates protein-protein interactions. B) In Homo
sapiens (Hs), the EEP domain (green) is unchanged between the two paralogs. The
LRR domain (orange) of Cnot6l is two amino acids shorter than the LRR of Cnot6, but
this appears to be a silent mutation. C) The large CNOT1 subunit is the core of the
Ccr4-NOTI complex and contains several different domains that other subunits bind
to. The LRR domain of Cnot6/l binds Caf1, which binds the MIF4G domain of
CNOT1. The pie-slice in Caf1 and Ccr4 indicates catalytic activity. (Winkler and
Balacco, 2013)
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functions in eukaryotic cells, with prominent activities associated with mRNA
metabolism and transcription activation and elongation (Kruk et al., 2011). The function
of Cnot6 and Cnot6l in the Ccr4-NOTI complex is to specifically degrade the poly(A) tail
of mRNAs that have been targeted for degradation (Morita et al., 2007). Caf1 is the
second catalytic subunit in Ccr4-NOTI and is a member of the DExD (Asp-Glu-x-Asp)
superfamily of proteins that have both RNAse and DNAse activity. All other subunits of
the Ccr4-NOTI complex are non-catalytic.
An interesting finding that involves Cnot6l was made in a recent investigation
that combined microarray analysis to access whole-genome changes in gene
expression and qRT-PCR to determine the relative stability (half-life) of mRNAs in
embryonic stem (ES) cells under different conditions (Sharova et al., 2009). The ES
cells were first cultured in the presence of leukemia inhibitory factor (LIF) to inhibits cell
differentiation. This line was split into two groups: 1) no LIF treatment (LIF-) and 2) with
retonoic acid (RA+), which is a factor that promotes differentiation. After allowing the
cells to proliferate, the researchers found that many genes that promote mRNA
degradation, such as Cnot4 and Cnot10, had decreased expression in both LIF- and
RA+ cells, suggesting that overall mRNA stability should be promoted in both groups.
This was not observed, however; they instead found that mRNA stability increased only
in RA+ cells. Interestingly, they found that Cnot6l expression had increased in both
groups. The authors note that an increase in Cnot6l expression would explain why
mRNA is less stable in LIF- cells, but it does not explain the enhanced mRNA stability in
RA+ cells (Sharova et al., 2009). This study suggests that RA signaling influences
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factors to inhibit the deadenylase activity of Cnot6l while maintaining its cellular
concentration.
Emx2 Could Potentially Modulate Cnot6l and QkI-7
Our past findings indicated that Cnot6l and QkI-7 both interact with Emx2, and
that Cnot6l and QkI-7 also interact, which suggests that these three proteins may work
within a complex to influence neocortical arealization and/or other developmental
events. Given that Cnot6l is commonly recruited to mRNAs that have been marked for
degradation and QkI-7 has been widely implicated as a factor that protects mRNAs, it is
possible that Emx2 may influence the selection of target mRNAs for either degradation
or protection. It is possible to contemplate numerous theoretical models that may shed
light on how these proteins work in a combinatorial manner to regulate cell growth
and/or differentiation by regulating transcription, translation, mRNA localization, or other
pathways.
Project Overview
Although yeast two-hybrid screening is a powerful method for identifying proteinprotein binding partners, it is necessary to provide supplemental evidence of the
interactions using a relatively robust technique that is less prone to false-positive
results. To satisfy this requirement, this project employed a method called the pull-down
assay to confirm the interactions. Briefly (Figure 10), in our version of the pull-down
assay, the bait protein of interest was attached to a protein called glutathione Stransferase (GST) via molecular cloning. The GST tag has specific affinity for a resin
material called Glutathione-agarose beads. The recombinant bait protein was
expressed in Escherichia coli (E. coli), extracted from the cells, and purified on the
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Figure 10. Schematic for the pull-down assay technique. (A) A GST tag is
linked to QkI-7 protein via molecular cloning to make it capable of binding to the
beads. After immobilizing GST-tagged QkI-7 on the beads, pure 6xHis-tagged
Emx2 protein is added to the preparation and is allowed to interact with QkI-7.
The mixture is subjected to extensive washing to test the strength of the
interaction. A significant amount of retained Emx2 indicates a positive interaction
with QkI-7. (B) Negative control; only the GST tag (without QkI-7) is immobilized
on the beads. After addition of Emx2 and extensive washing, nearly all Emx2
protein should be removed from the beads.
beads. Next, previously purified prey protein is added to the bead-bait mixture and the
prey protein subsequently becomes immobilized on the beads through the interaction
with the bait protein. The mixture of proteins is then extensively washed with a buffer
solution to remove non-specifically interacting proteins and thus tests the strength of the
bait-prey interaction relative to a GST-only bait negative control experiment. Finally, the
proteins are eluted from the beads with either 10 mM glutathione solution or by boiling
in SDS loading dye. The samples are then subjected to Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis (SDS-PAGE) and western blot analysis to visualize and
compare the amount of prey protein retained by the beads.
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In this project, the prey proteins used for pull-down assay were 6xHis-Emx2 and
6xHis-QkI-7. These were expressed in E. coli and purified in advance. The bait proteins
included GST (negative control), GST-Cnot6l, GST-Emx2, GST-QkI-5, GST-QkI-6 and
GST-QkI-7. These were also expressed in E. coli, but purified/immobilized on the beads
the day of the experiment. The original goal was to demonstrate positive protein-protein
binding between Emx2 and QkI-7, Emx2 and Cnot6l, and QkI-7 and Cnot6l. As
expected, all three interactions were confirmed with pull-down assay. Additionally,
6xHis-Emx2 prey protein was shown to bind GST-QkI-5 and GST-QkI-6 bait proteins.
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CHAPTER II
METHODS
The work described here utilized recombinant proteins expressed in, and purified
from, E. coli. Some of the expression plasmids used were available in the Kroll lab,
while others were constructed specifically for this project. These methods will first
discuss how the expression plasmids were made and how they were subsequently used
for protein expression and purification to produce proteins for the main objective,
confirmation of specific protein-protein interactions using pull-down assays.
Construction of Protein Expression Plasmids
Two different protein expression plasmids were used for the experiments: first,
pGEX-4T-1, which expresses proteins as an N-terminal glutathione-S-transferase (GST)
fusion; and second, pET24(a), which expresses proteins as a C-terminal 6xHis-tagged
fusion. The cloning process involves several steps, including amplification of the insert
sequence by polymerase chain reaction (PCR), digestion of the DNA insert and
recipient plasmid with appropriate restriction endonucleases (REs), and ligating the
insert DNA into the plasmid.
Four plasmids were constructed for this work: pGEX-4T-1-Emx2 (a GST-Emx2
fusion), pGEX-4T-1-QkI-5, pGEX-4T-1-QkI-6, and pET24(a)-QkI-7 (6xHis-QkI-7 fusion).
The primers, annealing temperatures, and restriction sites used for the various clonings
are listed in Table 1. Each of these clonings included the entire open reading frame
(ORF) of the protein, which were cloned in-frame with the GST or 6xHis tag.
For each amplification, multiple 50 μL PCR reactions were set up using the
following standard recipe and parameters: 1X Taq buffer without magnesium, 1.7 mM
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MgCl2, 20 ng template DNA, 20 pmol of each primer (sequences provided in Table 1),
1.5 μL DMSO, 400 μM dNTPs, and 0.4 μL Taq DNA polymerase. The annealing
temperature used was 59 ºC, as determined using the equation: annealing temp =
4(G+C) + 2(A+T) – 5 ºC, using only the region of the primer complimentary to the target
DNA sequence.
Table 1. Primer names, sequences, and restriction endonuclease sites used for
cloning. The restriction endonuclease sites are underlined in the primer sequences and
the restriction endonuclease (RE) enzyme used to generate sticky ends is also
provided.
Primer name
Primer sequence
RE
pGEX-4T-1-Emx2
Emx2-5-Y2H-EcoRI AAC TTA GAA TTC ATG TTT CAG CCG GCG CCC AA
EcoRI
Emx2-3-Y2H-XhoI
AAC TTA CTC GAG ATC GTC TGA GGT CAC ATC TAT TT
XhoI
pGEX-4T-1-QkI-5
QKI7-5-Eco-pET
AAC TTA GAA TTC ATG GTC GGG GAA ATG GAA ACG
EcoRI
QkI-5-3
AAC TTA GTC GAC GTT GCC GGT GGC GGC TCG
SalI
pGEX-4T-1-QkI-6
QKI7-5-Eco-pET
AAC TTA GAA TTC ATG GTC GGG GAA ATG GAA ACG
EcoRI
QkI-6-3
AAC TTA GTC GAC GCC TTT CGT TGG GAA AGC CAT
SalI
pET24(a)-QkI-7
QKI7-5-Eco-pET
AAC TTA GAA TTC ATG GTC GGG GAA ATG GAA ACG
EcoRI
QKI7-3-Hind-pET
AAC TTA AAG CTT ATG GGC TGA AAT ATC AGG CAT
HindIII

The PCR products were resolved in a 1% agarose gel by electrophoresis and the
DNA bands were cut from the gel and purified using the Zymoclean™ DNA Recovery
Kit (Zymo Research). The product was eluted with 40 μL dH2O and digested overnight
at 37 °C with the REs listed in Table 1. The digested products were resolved by agarose
gel electrophoresis and purified as before, with the exception of being eluted with 21 μL
dH2O. Seven microliters of the purified insert was mixed with 1 μL of 0.1 μg/μL recipient
plasmid (pGEX-4t-1 or pET24a) that had been previously digested with the same
combination of REs, 1 μL 10X T4 DNA ligase buffer, and 1 μL T4 DNA ligase. The
ligation reaction was incubated overnight at 16 °C. DH5α E. coli was transformed with
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the reaction product and several colonies were screened for the correct plasmid
construct using mini-prep and restriction-site digestion. Band patterns were visualized
using agarose gel electrophoresis.
Protein Expression
BL21(DE3) Rosetta2 E. coli was transformed with expression plasmids using
standard heat-shock procedure. Each day expression culture was grown in 100 mL LB
+ the appropriate antibiotic in a 500 mL flask, which was inoculated with 1 mL of
overnight culture grown in a 10 mL culture tube. The day culture was incubated at 37 °C
and 300 rpm with frequent monitoring of the optical-density at 600 nm (OD600nm) to
estimate bacterial concentration. For all bait and prey proteins in this project except
GST-Cnot6l, the cells were induced at an OD600nm of approximately 0.6 by adding 0.1
mM isopropyl β-D-1-thiogalactopyranoside (IPTG). Cultures were incubated for 2
additional hours at 37 °C and 300 rpm. For GST-Cnot6l, the expression culture was
incubated at 37 °C and 300 rpm and the OD600nm was monitored until it reached ~ 0.9,
at which time it was placed on ice with shaking at 200 rpm for 30 min. IPTG was then
added and expression was allowed to proceed for 12 hours at 18 °C and 200 rpm.
Cultures were subsequently split between two 50 mL screw-top tubes, centrifuged at
4,000 g and 4 °C for 20 min, and the pellets were stored at -20 °C until the cells were
lysed for protein extraction and purification.
Cell Lysis
Frozen E. coli pellets (representing 50 mL of expression culture) were
resuspended in 3.6 mL of the appropriate lysis/binding buffer supplemented with 400 μL
(total volume of 4 mL) of 10X protease inhibitors (SIGMAFAST™ Protease Inhibitor
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Cocktail Tablets, EDTA-Free) using repeated drawing and withdrawing actions with a
20-gauge needle. TGEM 0.1 (-) was the lysis/binding buffer used for bait proteins, while
Sodium Phosphate lysis/binding buffer (-) was used for prey proteins. The suspended
cells were divided between four individual 1.7 mL tubes on ice. The output control on
the Branson Sonicator 250 was set to 5 and the cells were sonicated for 10-12 sec. This
was repeated, with a one-minute rest period in between sonication steps, until the
mixture turned relatively clear. For the GST bait proteins, DTT and PMSF were added
following sonication, while only PMSF was added to the 6xHis prey proteins (DTT
interferes with Ni-agarose protein purification). Cell lysates were then centrifuged at
12,000 g and 4 °C for 20 min and stored on ice until ready for either column purification
(prey protein only) or long-term storage.
Purification of 6xHis-Emx2 and 6xHis-QkI-7 Prey Proteins
Each of the following steps was done at 4 °C. One milliliter (bed volume) of NiNTA agarose beads was washed twice with 10 bed volumes of dH2O and twice with
Sodium Phosphate lysis/binding buffer (-) in a 15 mL screw-top tube with centrifugation
at 700 g for 2 min. A lysate volume representing 50 mL of expression culture was added
to the beads in the 15 mL screw-top tube and incubated for 2 hours on an end-over-end
mixer. The mixture was gently poured into a clamped 15 mm x 130 mm column and the
beads were allowed to settle at the bottom of the column. Unbound material was
allowed to flow through the column, and then 30 mL of 20 mM imidazole wash buffer
was pumped through the column with a peristaltic pump set to a flow rate of 1 mL/min,
followed by 30 mL of 30 mM imidazole wash buffer and 30 mL of 40 mM imidazole
wash buffer. After washing the beads, 2 mL of 250 mM imidazole elution buffer was
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added and incubated with the beads for five minutes with frequent gentle agitations.
Beads were allowed to resettle in the column and the eluate was collected in 0.5-1 mL
fractions. The elution step was then repeated twice. All elution fractions were stored on
ice until dialysis.
The elution fractions were subjected to SDS-PAGE and Coomassie staining to
visualize which fractions had the highest concentration of protein. The best elution
fractions were then combined and loaded into a 3 mL dialysis cassette and dialyzed
against TGEM 0.1 (-) or TEM 0.1 (-) (see Supplemental Protocols). After dialysis, 0.2
mM PMSF and 1 mM DTT were added (and glycerol to 20% if TEM 0.1 was used for
dialysis). The purified protein was divided into 100 μL aliquots, frozen quickly (see
Supplemental Protocols), and stored at -70 °C. Prior to being used in pull-down assays,
the concentration of the purified protein was determined using SDS-PAGE and ImageJ.
Because of the low concentration of purified 6xHis-Emx2, bovine serum albumin (BSA)
was added to ~ 0.5 mg/ml to stabilize the protein.
Pull-Down Assay
The desired amount (total bed volumes varied between experiments) of
Glutathione-agarose beads were washed four times with 10 bed-volumes of TGEM 0.1
(-) in a 1.7 mL microcentrifuge tube with centrifugation at 500 g for 5 minutes (all
centrifugation steps involving Glutathione-agarose beads used these parameters). After
the final wash, three bed-volumes of TGEM 0.1 (+) (75 μL) was added to make a
suspension containing 25% beads. For each individual assay, 100 μL of the mixture (25
μL beads) was added to a 1.7 mL microcentrifuge tube and held on ice. The GST bait
protein lysate was thawed on ice and a volume corresponding to 10 μg of GST bait
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protein was added to a fresh 1.7 mL microcentrifuge tube on ice and if necessary
diluted with TGEM 0.1 (+) to a final volume of 200 μL. These samples were then
centrifuged at 12,000 g and 4 °C for 20 min to remove any insoluble material resulting
from the freeze-thaw process. The supernatants (containing GST bait proteins) were
removed and subsequently added to the glutathione-agarose bead beds (previously
prepared) and the mixtures were incubated at room temperature for 1-2 hours on an
end-over-end mixer. For the pull-down assay using 6xHis-QkI-7 prey, the beads were
washed with decreasing NaCl concentrations; first with 250 μL TGEM 1.0(+), second
with 250 μL TGEM 0.75 (+) and finally with 250 μL TGEM 0.1 (+). After the last wash,
75 μL TGEM 0.1 (+) was added to the bead beds and the tubes were stored on ice. For
the pull-down assay using 6xHis-Emx2 prey, the beads were washed 3 times with 250
μL HEPES/Tris (+). After the final wash, 75 μL of HEPES/Tris (+) was added to the
bead beds and the tubes were stored on ice.
The prey protein was thawed on ice and a volume corresponding to 200 ng (QkI7 prey) or 250 ng (Emx2 prey) was removed and diluted to 25 μL with either TGEM 0.1
(+) (QkI-7 prey) or HEPES/Tris (+) (Emx2 prey). The diluted prey was centrifuged at
12,000 g and 4 °C for 20 min and the supernatant containing prey protein was removed
and subsequently added to the tubes containing bait protein immobilized on beads. The
bait and prey mixture was incubated for at least 6 hours or overnight at 4 °C on an endover-end mixer. The mixture was then washed five times with either ice-cold NEN (-) or
TGEM 0.1 (-) (no particular preference). For experiments using the 6xHis-Emx2 prey,
the bound protein was eluted from beads using 25 μL of 10 mM glutathione elution
buffer (-) with incubation at room temperature and agitation. The mixture was
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centrifuged and the elution fraction (supernatant) was removed. After, 25 μL of 2xSDS
loading dye was added and the samples were boiled for five minutes. For experiments
using the 6xHis-QkI-7 prey, the bound protein was eluted from the beads using 25 μL of
2xSDS loading dye and boiling for five minutes. For SDS-PAGE, 20 μL of each sample
was loaded on to the gel. The amount of prey protein in the samples was visualized
using standard western blot procedure with rabbit anti-6xHis primary antibody (Abcam,
diluted 1:1000 in PBST) and donkey-anti-rabbit alkaline phosphatase conjugate
secondary antibody (Abcam, diluted 1:20,000 in PBST). Bands were resolved with BCIP
and NBT in AP developing buffer (Promega, 66 µL of 50 mg/mL NBT and 33 µL of 50
mg/mL NBT were added to 10 mL AP developing buffer).
Buffers
Note: Buffers with (+) contained PMSF and DTT that was added to 0.2 mM and 1 mM,
respectively, on the day of the experiment. Buffers with (-) contained no PMSF or DTT.
Ni-NTA agarose purification


Sodium Phosphate lysis/binding buffer: 50 mM NaH2PO4, 0.5 M NaCl, pH 7.9.



Sodium Phosphate wash buffer (with imidazole): to achieve the desired
concentration of imidazole, a 250 mM imidazole solution was first prepared by
adding 3 M Imidazole stock solution (below) to Sodium Phosphate lysis/binding
buffer. The pH was then adjusted to 7.9. The appropriate volume of the 250 mM
imidazole solution was then added to Sodium Phosphate lysis/binding buffer to
achieve the desired concentration of imidazole in the wash buffer.



3 M Imidazole stock solution: 3 M Imidazole, 500 mM NaCl, 17.5 mM NaH2PO4, 2.5
mM Na2HPO4, pH 6.0.
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Pull-down assay


TGEM 1.0: 1.0 M NaCl, 20 mM Tris-HCl, 1 mM EDTA, 5mM MgCl2, 20% glycerol,
0.1% IGEPAL-CA630, pH 7.9.



TGEM 0.75: 0.75 M NaCl, 20 mM Tris-HCl, 1 mM EDTA, 5mM MgCl2, 20% glycerol,
1% IGEPAL-CA630, pH 7.9.



TGEM 0.1: 0.1 M NaCl, 20 mM Tris-HCl, 1 mM EDTA, 5mM MgCl2, 20% glycerol,
0.1% IGEPAL-CA630, pH 7.9.



HEPES/Tris: 12 mM HEPES, 4 mM Tris/HCl, 50 mM NaCl, 10 mM KCl, 1 mM EDTA,
pH 7.9.



NEN: 150 mM NaCl, 1 mM EDTA, 0.5% IGEPAL-CA630, pH 6.5.



10 mM glutathione elution buffer: 50 mM Tris-HCl, 10 mM reduced glutathione, pH
8.0.

Western blot


PBST: 137 mM NaCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl, 0.1% (v/v)
Tween 20, pH 7.4.



AP developing Buffer: 0.1 M Tris-HCl, 5 mM MgCl2-6H2O, 100 mM NaCl, pH 9.5.
Supplemental Protocols

1. Quick-freezing proteins for long-term storage (ensure at least 20% glycerol before
freezing). Prepare a dry ice/100% ethanol bath. Briefly freeze tubes in the bath before
adding lysate. Divide lysate in to 0.1 mL aliquots. Submerge aliquots in the bath and
immediately store at -70 °C.
2. Dialysis. Make 1.8 L of TEM 0.1 or TGEM 0.1 (TEM 0.1 saves glycerol, but TGEM
0.1 is recommended). Hydrate dialysis cassette by submerging it in the buffer for >10
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min. Add ≤ 3 mL sample to the hydrated dialysis cassette and submerge cassette in 600
mL of buffer for 4 hours at 4 °C. In the evening, replace buffer with 600 mL fresh buffer
and continue dialysis overnight. In the morning, add 600 mL fresh buffer and dialyze for
2 hours. Carefully remove sample from cassette and if TEM 0.1 was used, add glycerol
to 20%. Add PMSF and DTT to 0.2 mM and 1 mM, respectively. Aliquot and quick
freeze.
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CHAPTER III
RESULTS
Cloning
All bait proteins were cloned into the expression plasmid pGEX-4T-1, which
fuses a glutathione S-transferase (GST) tag to the N-terminus of the protein. All prey
proteins were cloned into the expression plasmid pET24(a), which fuses a multihistidine (6xHis) tag to the C-terminus of the prey protein (Table 2). Kroll research
members in the past cloned the plasmids for expressing GST-Cnot6l, GST-QkI-7, and
6xHis-Emx2. The expression plasmids that I cloned were GST-QkI-5, GST-QkI-6, GSTEmx2 and 6xHis-QkI-7. Ligation products were transformed into DH5α E.coli and the
resulting colonies were grown and used for plasmid minipreps in order to identify
properly assembled constructs, which were identified by restriction enzyme digestion
analysis. This analysis used the same two restriction endonucleases used to clone the
inserts into the multiple cloning sites of the plasmids. The digestion fragments were
separated using agarose gel electrophoresis. As an example, confirmation of the pGEX4T-1-QkI-6 plasmid construct is shown below (Figure 11).
Table 2. DNA encoding bait and prey proteins and expression plasmids used for
cloning.
Bait proteins
GST
GST-QkI-5
GST-QkI-6
GST-QkI-7
GST-Cnot6l
GST-Emx2

Expression plasmid

Prey proteins

Expression plasmid

pGEX-4T-1

6xHis-Emx2
6xHis-QkI-7

pET24(a)
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Figure 11. Confirmation of the pGEX-4T-1-QkI-6
plasmid construct. QkI-6 was ligated into the EcoRI
and SalI restriction enzyme sites of pGEX-4T-1. DH5α
E. coli was transformed with the ligation product and
viable colonies were subjected to plasmid DNA
miniprep and digestion with EcoRI and SalI. The
product was visualized using agarose gel
electrophoresis stained with ethidium bromide. The
size (in kb) of the markers (lane 1) is shown. The
digested plasmid is shown in lane 2, with the plasmid
appearing at approximately 4.9 kb and the insert at
approximately 950 bp (actual size is 960 bp).

Expression of Bait and Prey Proteins in E. coli
Bait and prey expression plasmids were transformed into Rosetta2 E. coli. This
strain carries a plasmid called pRARE2 that generates tRNAs that are uncommon in E.
coli relative to mammalian cells. Prior to large scale expression and purification of bait
and prey proteins, the ability of Rosetta2 E coli to express the proteins of interest was
tested on a small scale (Figure 12). For example, Rosetta2 E.coli harboring either
pGEX-4T-1-QkI-7 or pET24(a)-Emx2 were grown to an OD600nm of ~0.6 and a 1 mL
sample was removed. Protein expression was then induced with 0.1 mM IPTG and after
two hours of expression, an additional 1 mL sample of the culture was removed. The
two cell pellets were mixed with 100 μL of 2xSDS-loading dye and boiled for five
minutes. The samples were resolved by SDS-PAGE and visualized with Coomassie
staining (Figure 12).
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Figure 12. Confirmation of GST-QkI-7 and 6xHis-Emx2 expression in Rosetta2 E.
coli. Lane 1, protein marker (sizes are indicated in kDa); lane 2, pGEX-4T-1-QkI-7
uninduced cells; lane 3, pGEX-4T-1-QkI-7 after being induced for 2 hours; lane 4,
pET24(a)-Emx2 uninduced cells; lane 5, pET24(a)-Emx2 after two hours of induction.
GST-QkI-7 is robustly expressed (black arrowhead) after induction, while 6xHis-Emx2
expression is relatively weak (red arrowhead). The predicted sizes of GST-QkI-7 and
6xHis-Emx2 are 62 kDa and 32 kDa, respectively.

Preparation to Conduct Pull-Down Assays
Part 1. Conditions for Immobilizing Bait Proteins on Glutathione-agarose Beads
Pull-down assays utilized freshly purified (the evening prior to the pull-down
assay) bait protein and prey protein that had been previously purified and stored at -70
ºC. The freshly purified bait protein was prepared from frozen aliquots of E. coli lysate
containing the bait protein. As it is preferable to have experiments be conducted using
consistent amounts of bait proteins, it was necessary to empirically determine the
appropriate volume of each bait protein lysate to use for the pull-down assay. Given that
GST-QkI-5, GST-QkI-6 and GST-QkI-7 are very similar proteins and all followed the
same procedure for protein expression, I predicted that they would all produce similar
concentrations of recombinant bait protein in the lysates. This was confirmed using
SDS-PAGE and Coomassie staining (data not shown). Therefore, only GST-QkI-7
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lysate was analyzed with ImageJ software to quantify the concentration of bait protein in
these three lysates (Figure 13). The concentration of GST protein (for the negative
control experiment) in lysate was also quantified using ImageJ (Figure 14). The
concentrations of GST-Emx2 and GST-Cnot6l in lysate was relatively low and using
ImageJ to estimate the concentration of these two bait proteins in lysate was not
possible.

Figure 13. Estimating GST-QkI-7 bait concentration using ImageJ. The pixel
intensity counts representing a series of BSA standards was used to generate a
standard curve in Microsoft Excel. The linear equation was used to solve for the amount
of GST-QkI-7 protein in 3.5 and 10 μL of lysate. Lane 1, 10 μL uninduced cells; lane 2,
10 μL 2 hour induced cells; lane 3, protein size marker (sizes in kDa are shown on the
left); lane 4, 3.5 μL lysate; lane 5, 10 μL lysate; lane 6, 1 μg BSA; lane 7, 2 μg BSA;
lane 8, 4 μg BSA; lane 9, 8 μg BSA; lane 10, 16 μg BSA. ImageJ analysis provided a
GST-QkI-7 concentration of 0.34 μg/μL. The apparent sizes of GST-QkI-7 and BSA are
very similar (62 kDa versus 66 kDa).
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Figure 14. Estimating GST bait concentration using ImageJ. The pixel intensity
counts representing the BSA standards were used to generate a standard curve in
Excel. The linear equation was used to solve for the amount of GST protein in 3.5 and
10 μL of lysate. Lane 1, uninduced cells; lane 2, induced cells; lane 3, marker; lane 4,
3.5 μL lysate; lane 5, 10 μL lysate; lane 6, 1 μg BSA; lane 7, 2 μg BSA; lane 8, 4 μg
BSA; lane 9, 8 μg BSA; lane 10, 16 μg BSA. ImageJ analysis provided a GST
concentration of 2.10 μg/μL. The size of GST is 26 kDa.

Since the concentrations of GST-Emx2 and GST-Cnot6l could not be estimated
by ImageJ analysis, several purification experiments were performed to determine the
volume of lysate needed to saturate a 10 μL Glutathione-agarose bead bed. GSTCnot6l purification is shown as an example (Figure 15); GST-Emx2 purification
produced similar results. Compared to the other bait proteins, much larger volumes of
GST-Emx2 and GST-Cnot6l lysates were needed to immobilize substantial amounts of
bait protein.

34

Figure 15. Adding increasing volumes of GST-Cnot6l lysate to empirically
determine the volume needed to saturate a 10 μL Glutathione-agarose bead bed.
Lysates were incubated with beads for 4 hr at 4 °C on an end-over-end mixer and
subsequently washed twice with TGEM 1.0 and twice with TGEM 0.1. Lane 1, marker;
lane 2, 20 μL lysate; lane 3, 30 μL lysate; lane 4, 50 μL lysate; lane 5, 8 μg BSA; lane 6,
4 μg BSA; lane 7, 2 μg BSA, lane 8, 1 μg BSA; lane 9, 0.5 μg BSA.

Using the estimated concentrations of GST and GST-QkI-7 in lysate, the volume
of lysate corresponding to approximately 150 pmol of each bait protein was incubated
with a 10 μL Glutathione-agarose bead bed to compare the relative amounts purified
protein (Figure 16). The molar amount of each bait protein purified was quantified using
ImageJ and subsequent calculations were performed to determine the adjusted volume
of lysate needed to achieve molar equivalence (Table 3). Prior to conducting pull-down
assays, the determined volume of lysate to use for each bait protein (using
approximately equimolar amounts) during the initial purification of bait was tested on a
10 μL bead bed (Figure 17).
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Figure 16. Estimating amounts of GST and GST-QkI-7 immobilized on 10 μL
Glutathione-agarose beads using ImageJ. Lysate volumes corresponding to 150
pmol of bait protein was incubated with beads for 4 hr at 4 °C on an end-over-end mixer
and subsequently washed twice with TGEM 1.0 and twice with TGEM 0.1. Bound
protein was eluted with SDS loading dye and boiling. Lane 1, marker; lane 2; 1.91 μL
GST lysate, lane 3, 28.1 μL GST-QkI-7 lysate; lane 4, 8 μg BSA; lane 5, 4 μg BSA; lane
6, 2 μg BSA; lane 7, 1 μg BSA; lane 8, 0.5 μg BSA; lane 9, 0.25 μg BSA.

Table 3. Estimating the correct volume of GST and GST-QkI-7 lysate to add to 10
μL beads in order to achieve molar equivalence.

Protein

MW
(kDa)

GST
GST-QkI-7

26
62

Bead
bed
Volume
(μL)
10
10

Lysate
volume
(μL)
1.91
28.1

Amount of
protein
immobilized
(μg)
1.67
1.23

Moles of
protein
immobilized
(pmol)
64.2
19.8

Moles
desired
(pmol)
20
20

Adjusted
lysate
volume
(μL)
0.6
28.4

This test assay suggests that GST-Emx2 and GST-Cnot6l bait proteins do not
bind to the beads with equal efficiently as GST or GST-QkI-7 (and the other GST-QkI
isoforms). Therefore, throughout the pull-down assay trials the molar amounts of GSTEmx2 and GST-Cnot6l immobilized were underrepresented compared to that of the
GST negative control. The weak binding efficiencies of these two baits was

36

compensated for by increasing the volume of lysate to the maximum allowable while
keeping the total reaction volume the same as GST or GST-QkI baits.

Figure 17. Comparing the amount of all GST bait proteins immobilized using 10
μL Glutathione-agarose beads. Lysate was incubated with beads for 4 hr at 4 °C on
an end-over-end mixer and subsequently washed 2 times with TGEM 1.0 and 2 times
with TGEM 0.1. Western blot used anti-GST primary antibody and alkaline phosphatase
secondary antibody. Bands were resolved with BCIP and NBT. Purified proteins were
eluted with 2x SDS loading dye and boiling. Lane 1, marker; lane 2, 0.6 μL GST lysate;
lane 3, 50 μL GST-Cnot6l lysate; lane 4, 30 μL GST-QkI-5 lysate; lane 5, 50 μL GSTQkI-5 lysate; lane 6, 30 μL GST-QkI-6 lysate; lane 7, 50 μL GST-QkI-6 lysate; lane 8,
30 μL GST-QkI-7 lysate; lane 9, 30 μL GST-Emx2 lysate; lane 10, 50 μL GST-Emx2
lysate.

These predetermined conditions for bait purification were then used for a series
of pull-down assays in which immobilized GST-baits were incubated with 6xHis-prey
proteins. Although positive results were obtained, these trials tended to yield lowintensity (weak) bands in the final western blot visualization of the retained prey protein
and did not photograph well (data not shown). Additionally, high background of 6xHisprey protein was often detected in the negative control experiment. These issues were
likely due to the repeated use of TGEM 1.0 (containing 1 M NaCl) when washing the
beads of nonspecifically bound prey protein. This high salt concentration has been
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reported to specifically precipitate Emx2 from high-density ribosomal particles (Nedelec
et al., 2004) and is likely the reason Emx2 was precipitating in the negative control
experiment.
To combat these issues, the Glutathione-agarose bead volume was increased to
from 10 μL to 25 μL and the amount of all bait proteins immobilized on beads was
increased by a factor of up to five (aiming for 100 pmol). Additionally, HEPES/Tris and
NEN buffers were adopted for the washing of bait and prey proteins, respectively.
These conditions have been shown to be effective for pull-down assays using a
homeodomain transcription factor (Hussain and Habener, 1999) However, further trials
showed that the best combination of buffers for each bait-prey pair needed to be
determined empirically, and TGEM buffers were incorporated in some experiments.
Another common issue with 6xHis-Emx2 prey was nonspecific binding of the protein to
Glutathione-agarose beads, which causes false-positive results. An alternative to using
2xSDS loading dye to elute proteins from Glutatione-agarose is using 10 mM
glutathione elution buffer. This elution method was employed for 6xHis-Emx2 prey
experiments to ensure that dissociation of the prey from the beads was due solely to the
selective release of the bait protein. Conversely, since 6xHis-QkI-7 prey did not bind
nonspecifically, eluting with 2xSDS loading dye and boiling was sufficient.
For convenience when repeatedly performing the pull-down assay, 200 μL of all
bait protein lysates (2 aliquots worth) was used, although this did not result in 100 pmol
of GST-Emx2 or GST-Cnot6l (Figure 18, Table 4). Much more than 200 μL of lysate
containing these bait proteins could have been used in the scaled-up version of the pull-
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down assay, but this was not exercised as it would have required the overall reaction
volumes to vary between experiments.

Figure 18. Comparing the amounts of GST bait proteins immobilized on 25 μL
Glutathione-agarose beads. Lysates were incubated with beads for one hour at room
temperature on an end-over-end mixer and subsequently washed 3 times with
HEPES/Tris buffer. Lane 1, 200 μL GST-Cnot6l lysate; lane 2, 200 μL GST-Emx2
lysate; lane 3, 200 μL GST-QkI-7 lysate; lane 4, 200 μL GST-QkI-7 lysate; lane 5, 6 μL
GST lysate; lane 6, 8 μg BSA; lane 8, 4 μg BSA; lane 7, 2 μg BSA; lane 8, 1 μg BSA;
lane 9, 0.5 μg BSA; lane 10, 0.25 μg BSA (no room on gel for marker). The arrowheads
mark the location of the various bait proteins. The moles of bait retained on the beads is
shown in Table 4.

Table 4. ImageJ analysis to determine the moles of GST-bait proteins retained on
25 μL of Glutathione-agarose beads.
Protein
MW (kDa)
µg immobilized
pmol immobilized
GST
26
1.8
70
GST-QkI-7
62
6.7
107
GST-QkI-6
61
4.6
75
GST-Emx2
54
0.90
17
GST-Cnot6l
88
2.4
27
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Preparation to Conduct Pull-Down Assays
Part 2. Quantification of Purified Prey Proteins
The two prey proteins (6xHis-Emx2 and 6xHis-QkI-7) were purified on a 1 mL NiNTA agarose bead bed using a column connected to a peristaltic buffer pump and the
best elution fractions (visualize with SDS-PAGE and Coomassie staining) were dialyzed
against TGEM 0.1 buffer. The purified preys were subsequently analyzed using ImageJ
in order to determine their approximate concentrations (Figures 19 & 20). Of the two
prey proteins, 6xHis-Emx2 was considerably dilute and BSA was added to 0.53 μg/μL to
enhance stability.

Figure 19. Estimating the concentration of purified 6xHis-Emx2 prey and BSA
(added) using ImageJ. Lane 1; marker, lane 2, uninduced cells; lane 3, induced cells;
lane 4, purified 6xHis-Emx2 (arrowhead) with BSA; lane 5, 0.5 μg BSA; lane 6, 1 μg
BSA; lane 7, 2 μg BSA; lane 8, 4 μg BSA; lane 9, 8 μg BSA; lane 10, 16 μg BSA.
Analysis determined that the concentrations of 6xHis-Emx2 was 0.017 μg/μL and BSA
was 0.53 μg/μL.
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Figure 20. Estimating purified 6xHis-QkI-7 prey concentration using ImageJ. Lane
1, marker; lane 2, 3 μL purified 6xHis-QkI-7; lane 3, 6 μL purified 6xHis-QkI-7; lane 4, 9
μL purified 6xHis-QkI-7 (arrowhead); lane 5, 8 μg BSA; lane 6, 4 μg BSA; lane 7; 2 μg
BSA; lane 8, 1 μg BSA; lane 9; 0.5 μg BSA; lane 10, 0.25 μg BSA. Analysis determined
that the concentration of 6xHis-QkI-7 was 0.080 μg/μL.
Preparation to Conduct Pull-Down Assays
Part 3. Empirical Determination of Pull-Down Assay Conditions
After determining the appropriate conditions for immobilizing the bait proteins and
quantifying the concentration of prey proteins, pilot pull-down assay experiments were
performed to determine to best amount of prey protein to use. Approximately 10 μg of
each bait (GST or GST-QkI-7) was incubated with 25 μL Glutathione-agarose beads for
one hour at room temperature on an end-over-end mixer. The beads were washed
three times with 250 μL HEPES/Tris buffer. The purified baits were resuspended in 75
μL HEPES/Tris buffer followed by addition of either 100 ng or 250 ng of purified 6xHisEmx2 prey, which was previously diluted to 25 μL with HEPES/Tris buffer. The 125 μL
final reaction volume containing beads, bait, and prey was incubated overnight at 4 °C
on an end-over-end mixer. The next morning, the beads were washed 4 times with 250
μL ice-cold NEN buffer. For elution, 25 μL of 10 mM glutathione elution buffer was
added to the beads and incubated at room temperature for 10 min with agitation. After
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centrifugation and removing the elution fraction, proteins remaining on the beads were
eluted with 25 μL of 2xSDS loading dye and boiling (Figure 21). This experiment
demonstrated that 6xHis-Emx2 prey either binds to the Glutathione-agarose beads
nonspecifically or that the Emx2 prey becomes insoluble due to the buffer conditions
(Figure 21, lanes 7-10). However, in either case, elution of GST-QkI-7 and 6xHis-Emx2
by addition of glutathione shows the specific interaction between GST-QkI-7 and 6xHisEmx2 (Figure 21, lanes 2-5).

Figure 21. Initial determination of conditions to demonstrate that 6xHis-Emx2
prey binds GST-QkI-7 bait. Two experiments, using either 100 ng 6xHis-Emx2 prey or
250 ng 6xHis-Emx2 prey, were performed using two different elution methods. Left of
marker: bound proteins were eluted with 10 mM glutathione elution buffer. Lane 1, 10
ng of 6xHis-Emx2 prey protein (input, arrowhead); lane 2, GST-QkI-7 bait incubated
with 250 ng prey; lane 3, GST bait incubated with 250 ng prey; lane 4, GST-QkI-7 bait
incubated with 100 ng prey; lane 5, GST bait incubated with 100ng prey; lane 6, marker
(sizes in kDa shown on left). Right of marker: proteins remaining on the beads were
eluted for a second time with SDS loading dye and boiling. Lane 7, GST bait incubated
with 100 ng prey; lane 8, GST-QkI-7 bait incubated with 100 ng prey; lane 9, GST bait
incubated with 100 ng prey; lane 10, GST-QkI-7 bait incubated with 250 ng prey.
Western blot used rabbit anti-6xHis primary antibody and donkey-anti-rabbit alkaline
phosphatase-conjugated secondary antibody. Bands were resolved with BCIP and NBT.

This experiment also revealed that it was necessary to use 250 ng of 6xHisEmx2 prey protein in order to achieve clear results (Figure 21, lanes 2 and 4). Thus, in

42

subsequent experiments using 6xHis-Emx2 as prey, 250 ng of the prey was used and
the bound proteins were eluted with glutathione.
Next, the bait and prey proteins were swapped, so that the bait was GST-Emx2
and the prey was 6xHis-QkI-7. Approximately 10 μg of each bait (GST or GST-Emx2)
protein was incubated with 25 μL Glutathione-agarose beads for one hour at room
temperature. The beads were washed three times with 250 μL HEPES/Tris buffer. The
purified baits were resuspended in 75 μL HEPES/Tris buffer and either 200 ng or 500
ng of purified 6xHis-QkI-7 prey, previously diluted to 25 μL with HEPES/Tris buffer, was
added. The 125 μL final reaction volume containing beads, bait, and prey was incubated
overnight at 4 °C on an end-over-end shaker. The next morning, the beads were
washed four times with 250 μL ice-cold NEN buffer. For elution, 25 μL of 10 mM
glutathione elution buffer was added to the beads and incubated at room temperature
for 10 min with agitation. After centrifugation and removing the elution fraction, proteins
remaining on the beads were eluted with 25 μL of 2xSDS loading dye and boiling
(Figure 22).
This experiment demonstrated that 6xHis-QkI-7 prey performs well and is not
retained in the beads in a nonspecific manner. The results of this experiment also
suggest that using the lesser amount of prey resulted in a stronger apparent association
between the GST-Emx2 bait and 6xHis-QkI-7 prey (Figure 22, lanes 8 and 10). Thus, in
subsequent experiments using 6xHis-QkI-7 as prey, 200 ng of prey protein was
sufficient to achieve clear results. It is worth noting, however, that a shift in apparent
size (from approximately 44 kDa to 55 kDa, although its calculated size is actually 37
kDa) was evident when 6xHis-QkI-7 prey was found bound to GST-Emx2.
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It is presently unclear why the 6xHis-QkI-7 prey shifts in size when it binds to GSTEmx2.

Figure 22. Initial determination that 6xHis-QkI-7 prey binds GST-Emx2 bait. Two
experiments, using either 200 ng 6xHis-Emx2 prey or 500 ng 6xHis-Emx2 prey, were
performed. Left of marker: bound proteins were eluted with 10 mM glutathione elution
buffer. Lane 1, 10 ng of 6xHis-QkI-7 prey protein (input, red arrowhead); lane 2, GSTEmx2 bait incubated with 500 ng prey; lane 3, GST bait incubated with 500 ng prey;
lane 4, GST-Emx2 bait incubated with 200 ng prey; lane 5, GST bait incubated with 200
ng prey; lane 6, marker (sizes in kDa shown on left). Right of marker: proteins remaining
on beads were eluted with SDS loading dye and boiling. Lane 7, GST bait incubated
with 200 ng prey; lane 8, GST-Emx2 bait incubated with 200 ng prey (black arrowhead);
lane 9, GST bait incubated with 500 ng prey; lane 10, GST-Emx2 bait incubated with
500 ng prey. Western blot used rabbit anti-6xHis primary antibody and donkey-antirabbit alkaline phosphatase-conjugated secondary antibody. Bands were resolved with
BCIP and NBT.

Pull-Down Assays to Verify Protein-Protein Interactions
The ability of 6xHis-Emx2 prey to bind to GST, GST-Cnot6l, GST-QkI-5, GSTQkI-6, and GST-QkI-7 baits was analyzed using the empirically determined conditions.
Approximately 10 μg of each bait protein was incubated with 25 μL Glutathione-agarose
beads for one hour at room temperature. The beads were washed three times with 250
μL HEPES/Tris buffer. The purified baits were resuspended in 75 μL HEPES/Tris buffer,
followed by addition of 250 ng of purified 6xHis-Emx2 previously diluted to 25 μL with
HEPES/Tris buffer. The 125 μL final reaction volume containing beads, bait, and prey
was incubated overnight at 4°C on an end-over-end shaker. The next morning, the
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beads were washed five times with 250 μL ice-cold NEN buffer and eluted with 25 μL of
10 mM glutathione elution buffer for 10 min with agitation. The eluates were analyzed by
SDS-PAGE and western blotting (Figure 23).
The ability of GST-QkI bait proteins to pull down Emx2 was confirmed in a
second experiment (Figure 24). Approximately 10 μg of each bait protein was incubated
with on 25 μL Glutathione-agarose beads for one hour at room temperature. The beads
were washed three times with 250 μL HEPES/Tris buffer. The purified baits were
resuspended in 75 μL HEPES/Tris buffer and added to 250 ng of purified 6xHis-Emx2,

Figure 23. Pull-down assay showing 6xHis-Emx2 prey binds GST-Cnot6l, GSTQkI-5, GST-QkI-6, and GST-QkI-7 baits. 6xHis-Emx2 prey were incubated with purified
baits overnight at 4 °C and washed five times with NEN. Lane 1, 10% Emx2 prey input;
lane 2, marker; lane 3, GST bait; lane 4, Cnot6l bait; lane 5, QkI-5 bait; lane 6, QkI-6
bait; lane 7, QkI-7 bait. Western blot used rabbit anti-6xHis primary antibody and
donkey-anti-rabbit alkaline phosphatase-conjugated secondary antibody. Bands were
resolved with BCIP and NBT.
which was previously diluted to 25 μL with HEPES/Tris buffer. The 125 μL final reaction
volume containing beads, bait and prey was incubated overnight at 4 °C on an endover-end shaker. The next morning, the beads were washed five times with 250 μL ice-
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cold NEN buffer and eluted with 25 μL of 10 mM glutathione elution buffer for 10 min
with agitation. The eluates were analyzed by SDS-PAGE and western blotting.
Next, the ability of 6xHis-Emx2 prey to bind to GST-Cnot6l was confirmed (Figure
25). Approximately 10 μg of each bait protein was incubated with 25 μL Glutathioneagarose beads for one hour at room temperature. Beads were washed three times with
250 μL HEPES/Tris buffer. The purified baits were resuspended in 75 μL HEPES/Tris

Figure 24. Pull-down assay confirming that 6x-His-Emx2 prey binds GST-QkI-5,
GST-QkI-6 and GST-QkI-7 baits. 6xHis-Emx2 prey were incubated with purified baits
overnight at 4 °C and washed five times with NEN. Lane 1, 10% Emx2 prey input; lane
2, marker; lane 3, QkI-7 bait; lane 4, QkI-6 bait; lane 5, QkI-5 bait; lane 6, GST bait.
Western blot used rabbit anti-6xHis primary antibody and donkey-anti-rabbit alkaline
phosphatase-conjugated secondary antibody. Bands were resolved with BCIP and NBT.
buffer and 250 ng of purified 6xHis-Emx2 diluted to 25 μL with HEPES/Tris buffer was
added. The 125 μL final reaction volume containing beads, bait and prey was incubated
overnight at 4 °C on an end-over-end shaker. The next morning, the beads were
washed five times with 250 μL ice-cold NEN buffer. The next morning, the beads were
washed five times with 250 μL ice-cold NEN buffer and eluted with 25 μL of 10 mM
glutathione elution buffer for 10 min with agitation. The eluates were analyzed by SDSPAGE and western blotting.
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The ability of 6xHis-QkI-7 prey to bind to GST, GST-QkI-6 (positive control),
GST-Cnot6l, and GST-Emx2 baits was analyzed using the empirically determined
conditions (Figure 26). Approximately 10 μg of each bait protein was incubated with on
25 μL Glutathione-agarose beads for one hour at room temperature. The beads were

Figure 25. Pull-down assay confirming that 6x-His-Emx2 prey binds GST-Cnot6l
bait. 6xHis-Emx2 prey were incubated with purified baits overnight at 4 °C and washed
prey five times with NEN. Lane 1, marker; lane 2, GST bait; lane 3, GST-Cnot6l bait;
lane 4, 10% 6xHis-Emx2 input. Western blot used rabbit anti-6xHis primary antibody
and donkey-anti-rabbit alkaline phosphatase-conjugated secondary antibody. Bands
were resolved with BCIP and NBT.
washed three times with 250 μL HEPES/Tris buffer. The purified baits were
resuspended in 75 μL HEPES/Tris buffer and added to 200 ng of purified 6xHis-QkI-7,
which was previously diluted to 25 μL with HEPES/Tris buffer. The 125 μL final reaction
volume containing beads, bait and prey was incubated overnight at 4 °C on an endover-end shaker. The next morning, the beads were washed five times with 250 μL icecold NEN buffer. For elution, 25 μL of 2xSDS loading dye was added and boiled for five
minutes. The eluates were analyzed by SDS-PAGE and western blotting.
This experiment demonstrates a strong interaction between 6xHis-QkI-7 prey
and GST-Emx2 bait (Figure 26, lane 4). Consistent with previous results (Figure 22,
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lane 8), 6xHis-QkI-7 prey increased in apparent size from 44 kDa to 55 kDa in the GSTEmx2 bait experiment. GST-Cnot6l bait showed no retained prey (Figure 26, lane 3).

Figure 26. Pull-down assay showing 6xHis-QkI-7 prey binds GST-Emx2 bait.
6xHis-QkI-7 prey were incubated with purified baits overnight at 4 °C and washed five
times with NEN. Lane 1, marker; lane 2, GST bait; lane 3, Cnot6l bait; lane 4, Emx2
bait; lane 5, QkI-6; lane 6, 10% 6xHis-QkI-7 input. Western blot used rabbit anti-6xHis
primary antibody and donkey-anti-rabbit alkaline phosphatase-conjugated secondary
antibody. Bands were resolved with BCIP and NBT.
This negative result is believed to be due to GST-Cnot6l washing excessively from the
beads when using HEPES/Tris buffer (a relatively strong wash buffer) during
purification. In subsequent experiments, a decreasing NaCl concentration gradient was
used instead to wash GST-Cnot6l bait and positive results were produced using 6xHisQkI-7 as prey.
The pull-down assay method used in Figure 26 was replicated (Figure 27, lanes
7-10) alongside trials that used a decreasing NaCl concentration gradient to wash the
baits (Figure 27, lanes 1-4). Approximately 10 μg of each bait protein was immobilized
on 25 μL Glutathione-agarose beads with incubation for one hour at room temperature.
For experiments in lanes 1-4, the beads were washed first with TGEM 1.0 (0.1%
IGEPAL), second with TGEM 0.75 (1% IGEPAL) and third with TGEM 0.1 (0.1%
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IGEPAL). For experiments in lanes 6-9, the beads were washed three times with
HEPES/Tris buffer and purified baits were resuspended in 75 μL HEPES/Tris. For both
experiments, the purified baits were resuspended in 75 μL TGEM 0.1 buffer and added
to 200 ng of purified 6xHis-QkI-7, which was previously diluted to 25 μL with TGEM 0.1.,
the 125 μL final reaction volume containing beads, bait and prey was incubated
overnight at 4 °C on an end-over-end shaker. The next morning, the beads were
washed five times with 250 μL ice-cold TGEM 0.1. For elution, 25 μL of 2xSDS loading
dye was added and boiled for five minutes. The eluates were analyzed by SDS-PAGE
and western blotting.

Figure 27. Pull-down assay showing 6xHis-QkI-7 prey binds GST-Cnot6l and GSTEmx2 baits. Two experiments were performed. The bait proteins to the left of the
marker were washed with a decreasing NaCl concentration gradient. Lane 1, GST bait;
lane 2, QkI-6 bait; lane 3, Cnot6l bait; lane 4, Emx2 bait; lane 5, marker. The bait
proteins to the right of the marker were washed with HEPES/Tris buffer. Lane 6, 10%
QkI-7 prey input (arrow head); lane 7, Emx2 bait; lane 8, Cnot6l bait; lane 9, QkI-6 bait;
lane 10, GST bait. Western blot used anti-6xHis primary antibody and alkaline
phosphatase secondary antibody. Bands were resolved with BCIP and NBT.

This experiment confirms that using HEPES/Tris wash buffer to purify the bait
proteins produces unsatisfactory results (Figure 27, lanes 7-10). Conversely,
experiments that purified bait proteins using a decreasing NaCl concentration gradient
produced strong results (Figure 27, lanes 1-4). GST-Cnot6l and GST-Emx2 baits
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(Figure 27, lanes 3 & 4, respectively) retained significant amounts of 6xHis-QkI-7 prey.
Again, the GST-Emx2 bait caused 6xHis-QkI-7 prey to increase in size by ~11 kDa
(Figure 27, lane 4), although a portion of 6xHis-QkI-7 prey remained 44 kDa in size.
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CHAPTER IV
DISCUSSION
This work confirmed that Emx2 binds Cnot6l and the QkI isoforms, and that
Cnot6l and QkI-7 are also binding partners (summarized in Figure 28). Further yeast
two-hybrid and pull down assays need to be performed to test whether the addition of a
third protein either forms a complex with the other two, or inhibits the protein-protein
interaction.

Figure 28. Summary of protein-protein interactions confirmed by pull-down
assays. Cnot6l bait interacts with QkI-7 and Emx2 prey. Emx2 and QkI-7 interact
when either protein is used as bait.
There are several aspects that need to be considered when deciding where to take the
future of this research. Extensive literature investigation is needed to identify all that is
already known about these proteins and any observations that have led other
researchers to pose interesting questions about their cellular functions. With this
information, hypotheses will be formulated and tested with the goal of elucidating the
molecular mechanism(s) involving these proteins.
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Neocortex Development and Emx2
The development of the neocortex takes place through a complex interplay of
cellular mechanisms, including the regulation of asymmetric vs. symmetric divisions of
glial progenitors in the VZ, the establishment of distinct transcription factor gradients
across the VZ, thalamocortical and corticofugal axonal guidance, and tangential
migration of interneurons from the GE (O’Leary and Sahara, 2008). Emx2 is a
homeodomain transcription factor expressed in a high caudal-medial to low rostrallateral gradient across the VZ that regulates the sizes and positions of the cortical areas
by specifying the area-identity of glutamatergic daughter neurons as they are generated
in the VZ. The abnormalities exhibited by Emx2 mutant mice have been well described,
but questions about the molecular mechanism(s) through which Emx2 acts during
neocortex development remain unanswered (Galli et al., 2002).
Despite the fact that neurogenesis is almost completely shut down in the adult
cortex, Emx2 has been identified in two small populations of mitotically active cells,
although neither of these cell types become incorporated into the neocortex (Zhao et al.,
2008). The first of these populations resides in the subependymal zone (SEZ) of the
adult lateral ventricles, and are astroglial cells that continue to divide during adulthood
(Gangemi et al., 2001). These daughter cells migrate to the olfactory bulb (OB) and
differentiate into GABAergic interneurons. The second population of Emx2-expressing
progenitors resides in the subgranular zone (SGZ) of the dentate gyrus (DG) in the
hippocampus. This population of cells produces glutamatergic neuroblasts that migrate
to the granular cell layer of the DG. It appears that the expression of Emx2 within this
population of cells helps to regulate the size of the pool of gluatamateric neuron
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progenitors in the adult hippocampus (Galli et al., 2002). The mechanism(s) involving
Emx2 in the SGZ and SEZ of the adult brain remain undescribed since most research to
date has focused on the important role of Emx2 during neocorticogenesis. It is possible
that the interactions between Emx2 and Cnot6l, Emx2 and the QkI isoforms, and Cnot6l
and QkI-7 confirmed here might be involved in these contexts and/or in the context of
neocortical development.
Emx2 and eIF4E
The authors of one study found that Emx2 interacts with the 5’ cap-binding
eukaryotic translation initiation factor 4E (eIF4E) in adult olfactory sensory neurons. In
addition to maintaining a nuclear role in this region, Emx2 is also found within axonal
regions of these neurons, where it binds eIF4E within ribosomal particles (Nedelec et
al., 2004). In general, eIF4E is one of three components constituting the eIF4F complex
(along with eIF4G and eIF4A), which typically functions as an on/off switch for mRNA
translation. The eIF4F complex is important for silencing mRNAs both during
cytoplasmic transport and while translation is otherwise repressed. A group of factors
referred to as eIF4E inhibitory proteins block mRNA translation by interacting with
eIF4E, which disrupts the eIF4E-eIF4G interaction. These eIF4E inhibitory proteins
either interact with eIF4E directly or are recruited to eIF4E by RNA binding proteins
(Richter and Sonenberg, 2005). When the repression is released, assembly of the
eIF4F complex on mRNAs commences, allowing eIF4E, bound the 5’ mRNA cap, to
interact with eIF4G, which in turn associates with the third eIF4F subunit, eIF4A.
Translation is initiated when eIF4A (an RNA helicase) recruits ribosomes to the mRNA
transcript (Richter and Sonenberg, 2005). Despite the clear interaction between Emx2
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and eIF4E, it is currently unknown whether this interaction stimulates or represses
mRNA translation, or is simply involved in the transportation of transcripts.
An example of eIF4E-mediated regulation of translation is the initial silencing of
α-CaMKII mRNA during transport to the dendrites of post-synaptic neurons in the
hippocampus. The α-CaMKII gene product is expressed locally at synapses to establish
a molecular ‘tag’ that promotes future signaling to the dendrite (Martin and Kosik, 2002).
The 3’ UTR of α-CaMKII mRNA harbors a cytoplasmic polyadenylation element (CPE)
that is recognized by CPE-binding protein (CPEB). In order to repress translation of the
transcript, a homeodomain protein called Maskin simultaneously binds CPEB and eIF4E
to disrupt the interaction between eIF4E and eIF4G (Figure 28). When translation of the
α-CaMKII mRNA needs to become active, signaling factors phosphorylate CPEB, which
in turn initiates the action of a poly(A) polymerase protein called Gld2 to add adenine
nucleotides to the 3’ end poly(A) tail of α-CaMKII mRNA, which creates binding sites for
poly(A) binding protein (PABP). Once bound to α-CaMKII mRNA, PABP promotes the
eIF4G-mediated displacement of Maskin by binding to eIF4E, which activates
translation of α-CaMKII (Martin and Kosik, 2002). This mechanism has been suggested
to promote synaptic plasticity and long-term memory (Berger-Sweeny et al., 2006).
Given the mRNA-binding capabilities of the QkI variants and the eIF4E-binding ability of
Emx2, it will be interesting to see whether these proteins function through a similar
mechanism to control translation of mRNAs in select cell types of the developing or
adult brain.
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Figure 29. Regulation of poly(A) tail length by CPEB and Maskin to
control mRNA translation. (top) Under conditions were the transcript is
repressed, Maskin disrupts the eIF4G-eIF4E interaction by binding both eIF4E
and CPEB. (bottom) Phosphorylation of CPEB initiates translation of the
silenced mRNA by inducing Gld2 to add adenine nucleotides to the 3’ tail. The
elongated tail recruits PABP, which promotes eIF4G to bind eIF4E and
displace Maskin from eIF4E to initiate translation. (Richter and Sonenberg,
2005)
Cnot6l and QkI-7
The enzymatic role that Cnot6l has in deadenylating (shortening) the poly(A) tail,
while incorporated in the Ccr4-NOTI complex, has been well-characterized and is
ubiquitous in nature. During early development, Cnot6l represses translation by
deadenylating poly(A) tails until it arrives at PABP, which is an inhibitor of Cnot6l
ribonuclease activity (Yamashita et al., 2005). In other cases, specific factors that
remove PABP from the poly(A) tail allow Cnot6l to continue degradation in the 3’ to 5’
direction in order to further down-regulate translation of target mRNAs. Given that QkI-7
recognizes and binds mRNAs containing QkI RREs and the role of Cnot6l as an mRNA
deadenylase, it seems plausible that QkI-7 recruits Cnot6l to deadenylate target
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mRNAs. Furthermore, since Emx2 binds to each of these proteins, it is possible that
Emx2 could regulate the ability of QkI-7 to recruit Cnot6l to target mRNAs. Thus, it will
be important to determine whether Cnot6l can still interact with QkI-7 in the presence of
Emx2.
Cnot6l and the QkI Isoforms Regulate p27 Kip1
During the differentiation of glial cells, the QkI isoforms regulate the export and
stability of p27Kip1 and myelin basic protein (MBP) mRNAs during oligodendrocyte and
astrocyte differentiation (Larocque and Richard, 2005). The primary function of p27Kip1 is
to inhibit cyclin-dependent kinase (CDK) proteins during the G1 phase, which arrests
cell-cycle re-entry and provides time for MBP expression and formation of compact
myelin (Larocque and Richard, 2005). Studies have found that during corticogenesis,
p27Kip1 regulates neural progenitor cell-cycle kinetics within the VZ and SVZ, in turn
modulating the frequency with which daughter neurons migrate to the various cortical
areas (Lukaszewicz et al, 2005). Interestingly, Cnot6l has also been implicated as a
regulator of p27Kip1 protein levels by shortening the poly(A) tail of the p27Kip1 mRNA.
This activity blocks p27 Kip1 protein expression and allows cells to re-enter the cell cycle
(Morita et al., 2007). Thus, Cnot6l and the QkI isoforms appear to work against each
other in the regulation of p27 Kip1 mRNA translation and thus the control of cell-cycle
progression. The interaction shown here between these two proteins may be a key
piece of missing information that could shed light on these regulatory processes.
Intriguingly, the authors of a recent study demonstrated that the unique Cterminus of QkI-7 promotes cytoplasmic polyadenylation of mRNA poly(A) tails by
binding and activating Gld2 in the same way the CBEP activates Gld2 (described
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above) (Yamagishi et al., 2016). This mechanism promotes translation of p27Kip1 and
heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) mRNAs. The protein
hnRNPA1 is involved in regulating the alternative splicing of myelin-associated
glycoprotein (MAG)—an integral factor during the myelination of oligodendrocytes (Zhao
et al., 2010). It is possible that the binding of Cnot6l and/or Emx2 to QkI-7 may regulate
the activation of Gld2 in this context.
Future Studies
The fact that Emx2 also interacts with eIF4E makes it temping to test whether
Emx2 is a factor that regulates mRNA translation by modulating the functions that
Cnot6l and the QkI isoforms have in mRNA stability. Given the prominent role that
Cnot6l has in the deadenylation of poly(A) tails, it would be interesting to see if adding
different combinations of these three proteins to prospective mRNAs influences the
length of the poly(A) tail by either inhibiting or promoting Cnot6l deadenylase activity.
Moreover, although Emx2 is not known to bind mRNA, several other homeodomain
proteins do bind and regulate mRNA (Dabnau and Struhl, 1996). Performing RNAbinding assays could potentially identify mRNA targets of Emx2. Interesting mRNA
candidates would be the transcripts that QkI-7 is known to regulate, including p27 Kip1,
MBP, and hnRNPA1, and transcripts that encode proteins with bordered expression in
the cortical plate, which includes the cadherin proteins (Cad6 & Cad8) and serotonin
receptor proteins.
In addition to being expressed in various regions of the developing brain, Emx2 is
strongly expressed in other regions of the developing mouse embryo, including the
reproductive system (Pellegrini et al., 2001), urinary system (Simeone et al., 1992),
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inner ear (Diez-Roux et al., 2011), skeleton (Diez-Roux et al., 2011), and epidermis
(Diex-Roux et al., 2011). The role that Emx2 has in the development of these structures
has received little attention and most of what is known is very recent. It would be
interesting to test whether Cnot6l and/or QkI-7 are also expressed in these regions.
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